Management of hypertension in patients with coronary artery disease

被引:0
作者
Ismail, Haisam [1 ]
Makaryus, Amgad N. [1 ]
机构
[1] Hofstra Univ, North Shore Univ Hosp, Hofstra North Shore LIJ Sch Med, Dept Cardiol, 300 Community Dr, Manhasset, NY 11030 USA
关键词
ACE inhibitors; ARBs; beta-blockers; calcium-channel blockers; coronary artery disease; diabetes mellitus; diuretics; hypertension; renin-angiotensin-aldosterone system;
D O I
10.1586/ERC.11.127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is the most prevalent and significant modifiable risk factor in individuals with concomitant coronary artery disease. The number of individuals with hypertension is substantially increasing every year. It has been shown in several studies that it is imperative to effectively control blood pressure in order to reduce the risk of adverse cardiovascular events. There are many classes of medications that can help control blood pressure in individuals with hypertension and coronary artery disease. The management of blood pressure in this high-risk population continues to be a challenge, especially as more people survive myocardial infarctions and the prevalence of disease such as diabetes mellitus increases as the population continues to age. In this article, we will review the different therapeutic antihypertensive agents recommended by the different societies on hypertension including the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, and the challenges faced in special cases of resistant hypertension.
引用
收藏
页码:1271 / 1277
页数:7
相关论文
共 47 条
  • [1] [Anonymous], 2003, CARDIOVASC J S AFR, V14, P208
  • [2] ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension
    Aronow, Wilbert S.
    Fleg, Jerome L.
    Pepine, Carl J.
    Artinian, Nancy T.
    Bakris, George
    Brown, Alan S.
    Ferdinand, Keith C.
    Forciea, Mary Ann
    Frishman, William H.
    Jaigobin, Cheryl
    Kostis, John B.
    Mancia, Giuseppi
    Oparil, Suzanne
    Ortiz, Eduardo
    Reisin, Efrain
    Rich, Michael W.
    Schocken, Douglas D.
    Weber, Michael A.
    Wesley, Deborah J.
    Harrington, Robert A.
    Bates, Eric R.
    Bhatt, Deepak L.
    Bridges, Charles R.
    Eisenberg, Mark J.
    Ferrari, Victor A.
    Fisher, John D.
    Gardner, Timothy J.
    Gentile, Federico
    Gilson, Michael F.
    Hlatky, Mark A.
    Jacobs, Alice K.
    Kaul, Sanjay
    Moliterno, David J.
    Mukherjee, Debabrata
    Rosenson, Robert S.
    Stein, James H.
    Weitz, Howard H.
    Wesley, Deborah J.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2011, 5 (04) : 259 - 352
  • [3] Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial
    Bakris, GL
    Fonseca, V
    Katholi, RE
    McGill, JB
    Messerli, FH
    Phillips, RA
    Raskin, P
    Wright, JT
    Oakes, R
    Lukas, MA
    Anderson, KM
    Bell, DSH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18): : 2227 - 2236
  • [4] Relation of Beta-Blocker-Induced Heart Rate Lowering and Cardioprotection in Hypertension
    Bangalore, Sripal
    Sawhney, Sabrina
    Messerli, Franz H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (18) : 1482 - 1489
  • [5] The Foundation Role of Beta Blockers Across the Cardiovascular Disease Spectrum: A Year 2009 Update
    Black, Henry R.
    Greenberg, Barry H.
    Weber, Michael A.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2010, 123 (11)
  • [6] Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial
    Black, HR
    Elliott, WJ
    Grandits, G
    Grambsch, P
    Lucente, T
    White, WB
    Neaton, JD
    Grimm, RH
    Hansson, L
    Lacourcière, Y
    Muller, J
    Sleight, P
    Weber, MA
    Williams, G
    Wittes, J
    Zanchetti, A
    Anders, RJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16): : 2073 - 2082
  • [7] Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled
    Bramlage, P
    Pittrow, D
    Wittchen, HU
    Kirch, W
    Boehler, S
    Lehnert, H
    Hoefler, M
    Unger, T
    Sharma, AM
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (10) : 904 - 910
  • [8] Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
    Calhoun, David A.
    Jones, Daniel
    Textor, Stephen
    Goff, David C.
    Murphy, Timothy P.
    Toto, Robert D.
    White, Anthony
    Cushman, William C.
    White, William
    Sica, Domenic
    Ferdinand, Keith
    Giles, Thomas D.
    Falkner, Bonita
    Carey, Robert M.
    [J]. HYPERTENSION, 2008, 51 (06) : 1403 - 1419
  • [9] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [10] Cooper-DeHoff R, JAMA, V304